Lung-Delivered IL-10 Therapy Elicits Beneficial Effects via Immune Modulation in Organic Dust Exposure-Induced Lung Inflammation
-
2024/04/02
Details
-
Personal Author:
-
Description:Efficacious therapeutic options capable of resolving inflammatory lung disease associated with environmental and occupational exposures are lacking. This study sought to determine the preclinical therapeutic potential of lung-delivered recombinant interleukin (IL)-10 therapy following acute organic dust exposure in mice. Here, C57BL/6J mice were intratracheally instilled with swine confinement organic dust extract (ODE) (12.5%, 25%, 50% concentrations) with IL-10 (1 µg) treatment or vehicle control intratracheally-administered three times: 5 hr post-exposure and then daily for 2 days. The results showed that IL-10 treatment reduced ODE (25%)-induced weight loss by 66% and 46% at Day 1 and Day 2 post-exposure, respectively. IL-10 treatment reduced ODE (25%, 50%)-induced lung levels of TNFa (-76%, -83% [reduction], respectively), neutrophil chemoattractant CXCL1 (-51%, -60%), and lavage fluid IL-6 (-84%, -89%). IL-10 treatment reduced ODE (25%, 50%)-induced lung neutrophils (-49%, -70%) and recruited CD11cintCD11b+ monocyte-macrophages (-49%, -70%). IL-10 therapy reduced ODE-associated expression of antigen presentation (MHC Class II, CD80, CD86) and inflammatory (Ly6C) markers and increased anti-inflammatory CD206 expression on CD11cintCD11b+ cells. ODE (12.5%, 25%)-induced lung pathology was also reduced with IL-10 therapy. In conclusion, the studies here showed that short-term, lung-delivered IL-10 treatment induced a beneficial response in reducing inflammatory consequences (that were also associated with striking reduction in recruited monocyte-macrophages) following acute complex organic dust exposure. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:1547-691X
-
Document Type:
-
Funding:
-
Genre:
-
Place as Subject:
-
CIO:
-
Topic:
-
Location:
-
Volume:21
-
Issue:1
-
NIOSHTIC Number:nn:20069792
-
Citation:J Immunotoxicol 2024 Apr; 21(1):2332172
-
Contact Point Address:Aaron D. Schwab, Division of Allergy and Immunology, Nebraska Medical Center, Omaha, NE 68198, USA
-
Email:aaron.schwab@unmc.edu
-
Federal Fiscal Year:2024
-
NORA Priority Area:
-
Performing Organization:University of Nebraska Medical Center - Omaha
-
Peer Reviewed:True
-
Start Date:20110901
-
Source Full Name:Journal of Immunotoxicology
-
End Date:20270831
-
Collection(s):
-
Main Document Checksum:urn:sha-512:f256f8fbea66c46f3e150675243971d3cd0e10587aa09f194314918e3552e86598c47fbe74a40939aed9f3225d398dc13c0fc787ef1ba9421f122aae21c6b4da
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like